REMEDYCON PHARMACEUTICAL PRIVATE LIMITED
| CIN | U21001UP2025PTC230840 |
| ROC Code | ROC Kanpur |
| Company Class | Private |
| Company Category | Company limited by shares |
| Activity Description | |
| Active Compliance | |
| Pan |
| Date of Inc. | 2025-08-26 |
| Date of AGM | |
| Date of B/S | |
| Company Status | Inactive for e-filing |
| CIRP | |
| Address other than R/o |
| Authorised Capital | ₹100000 |
| Paid up Capital | ₹100000 |
| Listing Status | Unlisted |
| Filing status | |
| Registered Address | 448/038(161/5A) NAGARIYA Lucknow Thakurganj Uttar Pradesh India 226003 |
CHARGES
| Sr No | Charge ID | Charge Holder | SRN | Amount | Created Date | Modified Date | Date Satisfied | Address |
|---|
GSTIN DETAILS
Related Companies With Similar Activity Code
This information is available to only logged in users.
FAQ'S ON REMEDYCON PHARMACEUTICAL PRIVATE LIMITED
REMEDYCON PHARMACEUTICAL PRIVATE LIMITED having CIN U21001UP2025PTC230840 is old Public company incorporated with MCA on 26 Aug, 2025.
REMEDYCON PHARMACEUTICAL PRIVATE LIMITED is listed in the class of Private and classified as Company limited by shares.
This company is registered at Registrar of Companies (ROC), ROC Kanpur with an Authorized Share Capital of ₹100,000 and paid-up capital is ₹100,000.
Address and contact details of REMEDYCON PHARMACEUTICAL PRIVATE LIMITED are as follows:
- Registered Address: 448/038(161/5A) NAGARIYA Lucknow Thakurganj Uttar Pradesh India 226003
The directors of REMEDYCON PHARMACEUTICAL PRIVATE LIMITED can be found in the Directors section above. For detailed information about each director, please refer to the Directors table.
The charges against REMEDYCON PHARMACEUTICAL PRIVATE LIMITED can be found in the Charges section above. For detailed information about each charge, please refer to the Charges table.
For more information about REMEDYCON PHARMACEUTICAL PRIVATE LIMITED, you can visit our website or contact the company directly using the contact details provided above. Additionally, you can explore other sections of this profile for more insights.